Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-24-007290

Options or other derivatives

  • PRESIDENT AND CEO acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Aggarwal Sumit · PRESIDENT AND CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-24 Grant or award : show line 1 in the form Restricted Stock Units +60,000 60,000 D
Loading xslF345X05/tm244260-1_4seq1.xml…